Protagonist Therapeutics, Inc. (PTGX) has a consensus analyst rating of Buy, based on 26 analysts covering the stock. Of those, 25 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for PTGX is $113.60, representing a +8.5% upside from the current price of $104.72. Price targets range from a low of $108.00 to a high of $121.00.
